Sfoglia per Autore
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
2011 De Iaco P.; Musto A.; Orazi L.; Zamagni C.; Rosati M.; Allegri V.; Cacciari N.; Al-Nahhas A.; Rubello D.; Venturoli S.; Fanti S.
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
2011 Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A.
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment
2012 Taffurelli M; Montroni I; Santini D; Zamagni C; Fiacchi M; Zanotti S; Pellegrini A; Ugolini G
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma.
2012 Stella F.; Dell'Amore A.; Dolci G.; Cassanelli N.; Caroli G.; Zamagni C.; Bini A.
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance
2012 Guerra F.; Perrone A.M.; Kurelac I.; Santini D.; Ceccarelli C.; Cricca M.; Zamagni C.; De Iaco P.; Gasparre G.
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers
2014 Flora Guerra;Giulia Girolimetti;Anna Myriam Perrone;Martina Procaccini;Ivana Kurelac;Claudio Ceccarelli;Dario De Biase;Giacomo Caprara;Claudio Zamagni;Pierandrea De Iaco;Donatella Santini;Giuseppe Gasparre
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points.
2014 Perrone, Am; Zamagni, C; De Iaco, P
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs
2015 Diemberger, Igor; Massaro, Giulia; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Martignani, Cristian; Ziacchi, Matteo; Biffi, Mauro; Bernardi, Alessandra; Cacciari, Nicoletta; Zamagni, Claudio; Boriani, Giuseppe
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report
2017 Minichillo, Santino; Gallelli, Ilaria; Barbieri, Elena; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Dall'Olio, Massimo; Rapezzi, Claudio; Zamagni, Claudio
Liquid biopsy in the diagnosis of HPV DNA in breast lesions
2018 De Carolis, Sabrina; Pellegrini, Alice; Santini, Donatella; Ceccarelli, Claudio; De Leo, Antonio; Alessandrini, Federica; Arienti, Chiara; Pignatta, Sara; Tesei, Anna; Mantovani, Vilma; Zamagni, Claudio; Taffurelli, Mario; Sansone, Pasquale; Bonafé, Massimiliano; Cricca, Monica
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach
2018 Nannini, Margherita*; Dondi, Giulia; Santini, Donatella; De Leo, Antonio; Dei Tos, Angelo Paolo; Zamagni, Claudio; Saponara, Maristella; Gatto, Lidia; Nigro, Concetta; Bertaccini, Paola; Zompatori, Maurizio; De Iaco, Pierandrea; Perrone, Anna Myriam; Pantaleo, Maria Abbondanza
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm.
2019 G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zamagni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial
2019 Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.; Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F.
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed
2019 Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D.
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer
2020 Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Rubner M.; Fasching P.A.; Wurfel W.; Zamagni C.
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results
2020 Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification
2021 De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S.; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C.
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
2021 Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, Anna Myriam Perrone, Pierandrea De Iaco, Antonio De Leo
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak
2021 Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P.
Radiotherapy in uterine sarcoma: a narrative review of international guidelines
2021 Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; Buwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. | De Iaco P.; Musto A.; Orazi L.; Zamagni C.; Rosati M.; Allegri V.; Cacciari N.; Al-Nahhas A.; Rub...ello D.; Venturoli S.; Fanti S. | 2011-01-01 | EUROPEAN JOURNAL OF RADIOLOGY | - | 1.01 Articolo in rivista | - |
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. | Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia ...S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A. | 2011-01-01 | THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment | Taffurelli M; Montroni I; Santini D; Zamagni C; Fiacchi M; Zanotti S; Pellegrini A; Ugolini G | 2012-01-01 | THE BREAST | - | 1.01 Articolo in rivista | - |
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. | Stella F.; Dell'Amore A.; Dolci G.; Cassanelli N.; Caroli G.; Zamagni C.; Bini A. | 2012-01-01 | ANNALS OF THORACIC SURGERY | - | 1.01 Articolo in rivista | - |
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance | Guerra F.; Perrone A.M.; Kurelac I.; Santini D.; Ceccarelli C.; Cricca M.; Zamagni C.; De Iaco P....; Gasparre G. | 2012-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers | Flora Guerra;Giulia Girolimetti;Anna Myriam Perrone;Martina Procaccini;Ivana Kurelac;Claudio Cecc...arelli;Dario De Biase;Giacomo Caprara;Claudio Zamagni;Pierandrea De Iaco;Donatella Santini;Giuseppe Gasparre | 2014-01-01 | MODERN PATHOLOGY | - | 1.01 Articolo in rivista | - |
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. | Perrone, Am; Zamagni, C; De Iaco, P | 2014-01-01 | EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs | Diemberger, Igor; Massaro, Giulia; Cubelli, Marta; Rubino, Daniela; Quercia, Sara; Martignani, Cr...istian; Ziacchi, Matteo; Biffi, Mauro; Bernardi, Alessandra; Cacciari, Nicoletta; Zamagni, Claudio; Boriani, Giuseppe | 2015-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report | Minichillo, Santino; Gallelli, Ilaria; Barbieri, Elena; Cubelli, Marta; Rubino, Daniela; Quercia,... Sara; Dall'Olio, Massimo; Rapezzi, Claudio; Zamagni, Claudio | 2017-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | 12885_2017_Article_3712.pdf |
Liquid biopsy in the diagnosis of HPV DNA in breast lesions | De Carolis, Sabrina; Pellegrini, Alice; Santini, Donatella; Ceccarelli, Claudio; De Leo, Antonio;... Alessandrini, Federica; Arienti, Chiara; Pignatta, Sara; Tesei, Anna; Mantovani, Vilma; Zamagni, Claudio; Taffurelli, Mario; Sansone, Pasquale; Bonafé, Massimiliano; Cricca, Monica | 2018-01-01 | FUTURE MICROBIOLOGY | - | 1.01 Articolo in rivista | - |
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach | Nannini, Margherita*; Dondi, Giulia; Santini, Donatella; De Leo, Antonio; Dei Tos, Angelo Paolo; ...Zamagni, Claudio; Saponara, Maristella; Gatto, Lidia; Nigro, Concetta; Bertaccini, Paola; Zompatori, Maurizio; De Iaco, Pierandrea; Perrone, Anna Myriam; Pantaleo, Maria Abbondanza | 2018-01-01 | CLINICAL MEDICINE INSIGHTS: ONCOLOGY | - | 1.01 Articolo in rivista | A Single-Centre Experience on the Management of Adenosarcoma.pdf |
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. | G. Santandrea, A. De Leo, C. Ceccarelli, G. Barbero, S. Ferrari, D. Turchetti, D. Rubino, C. Zama...gni, G. Dondi, A.M. Perrone, P. De Iaco, D. Santini. | 2019-01-01 | PATHOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial | Dieci M.V.; Bisagni G.; Brandes A.A.; Frassoldati A.; Cavanna L.; Giotta F.; Aieta M.; Gebbia V.;... Musolino A.; Garrone O.; Donadio M.; Rimanti A.; Beano A.; Zamagni C.; Soto Parra H.; Piacentini F.; Danese S.; Ferro A.; Cagossi K.; Sarti S.; Gambaro A.R.; Romito S.; Bazan V.; Amaducci L.; Moretti G.; Foschini M.P.; Balduzzi S.; Vicini R.; D'Amico R.; Griguolo G.; Guarneri V.; Conte P.F. | 2019-01-01 | BMC MEDICINE | - | 1.01 Articolo in rivista | HER2 2019.pdf |
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed | Ceccarelli C.; De Leo A.; Chieco P.; Zamagni C.; Zamagni A.; Rubino D.; Taffurelli M.; Santini D. | 2019-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | PlosONE Ceccarelli et al. journal.pone.0217937-1.pdf |
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer | Wurfel F.M.; Wirtz R.M.; Winterhalter C.; Taffurelli M.; Santini D.; Mandrioli A.; Veltrup E.; Ru...bner M.; Fasching P.A.; Wurfel W.; Zamagni C. | 2020-01-01 | GEBURTSHILFE UND FRAUENHEILKUNDE | - | 1.01 Articolo in rivista | a-1128-6664(1).pdf |
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results | Cortesi, Laura; Baldassarri, Bruna; Ferretti, Stefano; Razzaboni, Elisabetta; Bella, Mariangela; ...Bucchi, Lauro; Canuti, Debora; De Iaco, Pierandrea; De Santis, Giorgio; Falcini, Fabio; Galli, Vania; Godino, Lea; Leoni, Maurizio; Perrone, Anna Myriam; Pignatti, Marco; Saguatti, Gianni; Santini, Donatella; Sassoli de'Bianchi, Priscilla; Sebastiani, Federica; Taffurelli, Mario; Tazzioli, Giovanni; Turchetti, Daniela; Zamagni, Claudio; Naldoni, Carlo | 2020-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Cortesi_et_al-2020-Cancer_Medicine.pdf |
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification | De Leo A.; de Biase D.; Lenzi J.; Barbero G.; Turchetti D.; Grillini M.; Ravegnini G.; Angelini S....; Zamagni C.; Coluccelli S.; Dondi G.; De Iaco P.; Perrone A.M.; Tallini G.; Santini D.; Ceccarelli C. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | DeLeo2021cancers-13-00950.pdf |
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma | Giacomo Santandrea, Claudio Ceccarelli, Donatella Santini, Daniela Turchetti, Claudio Zamagni, An...na Myriam Perrone, Pierandrea De Iaco, Antonio De Leo | 2021-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak | Perrone A.M.; Dondi G.; Giunchi S.; De Crescenzo E.; Boussedra S.; Tesei M.; D'Andrea R.; De Leo ...A.; Zamagni C.; Morganti A.G.; De Palma A.; De Iaco P. | 2021-01-01 | GYNECOLOGIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
Radiotherapy in uterine sarcoma: a narrative review of international guidelines | Ferioli, Martina; Galuppi, Andrea; Perrone, Anna Myriam; De Iaco, Pierandrea; Zamagni, Claudio; B...uwenge, Milly; Morganti, Alessio Giuseppe; Cammelli, Silvia | 2021-01-01 | GYNECOLOGY AND PELVIC MEDICINE | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile